Archive | May, 2012

Early Detection is Key in Treating Actos Bladder Cancer

It’s important that Actos users be able to recognize the symptoms of bladder cancer. The Type 2 diabetes drug Actos (pioglitazone) has been linked to an increased risk of certain complications, including bladder cancer. The key to treating bladder cancer successfully is catching the disease early and it’s important for Actos users to be able […]

Read More »

Protecting Your Health: What Actos Users Need to Know

Actos (pioglitazone) was first approved in 1999 for the treatment of Type 2 diabetes in adult patients. In recent years, the drug has been linked to an increased risk for certain complications, including the development of bladder cancer. If you have taken or are currently taking Actos, you need to know what you can do […]

Read More »